miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21

被引:56
|
作者
Xiao, Junjie [1 ,2 ]
Bei, Yihua [1 ,2 ]
Liu, Jingqi [3 ]
Dimitrova-Shumkovska, Jasmina [1 ,4 ]
Kuang, Dapeng [3 ]
Zhou, Qiulian [1 ,2 ]
Li, Jin [1 ,2 ]
Yang, Yanning [3 ]
Xiang, Yang [5 ,6 ]
Wang, Fei [3 ]
Yang, Changqing [3 ]
Yang, Wenzhuo [3 ]
机构
[1] Shanghai Univ, Sch Life Sci, Expt Ctr Life Sci, Regenerat & Ageing Lab, Shanghai, Peoples R China
[2] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China
[3] Tongji Univ, Sch Med, Tongji Hosp, Div Gastroenterol & Hepatol,Digest Dis Inst, Shanghai 200092, Peoples R China
[4] Univ Ss Cyril & Methodius, Fac Nat Sci & Math, Dept Expt Biochem & Physiol, Skopje, Macedonia
[5] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China
[6] Nanjing Univ, Dept Biochem, Nanjing 210008, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
exercise; miR-212; FGF-21; NAFLD; steatosis; GROWTH-FACTOR; 21; INDUCED OBESE MICE; CARDIAC-HYPERTROPHY; INSULIN SENSITIVITY; LIPID-ACCUMULATION; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; CANCER CELLS; DISEASE; MICRORNAS;
D O I
10.1111/jcmm.12733
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is associated with obesity and lifestyle, while exercise is beneficial for NAFLD. Dysregulated microRNAs (miRs) control the pathogenesis of NAFLD. However, whether exercise could prevent NAFLDvia targeting microRNA is unknown. In this study, normal or high-fat diet (HF) mice were either subjected to a 16-week running program or kept sedentary. Exercise attenuated liver steatosis in HF mice. MicroRNA array and qRT-PCR demonstrated that miR-212 was overexpressed in HF liver, while reduced by exercise. Next, we investigated the role of miR-212 in lipogenesis using HepG2 cells with/without long-chain fatty acid treatment (+/- FFA). FFA increased miR-212 in HepG2 cells. Moreover, miR-212 promoted lipogenesis in HepG2 cells (+/- FFA). Fibroblast growth factor (FGF)-21, a key regulator for lipid metabolism, was negatively regulated by miR-212 at protein level in HepG2 cells. Meanwhile, FFA downregulated FGF-21 both at mRNA and protein levels in HepG2 cells. Also, FGF-21 protein level was reduced in HF liver, while reversed by exercise in vivo. Furthermore, siRNA-FGF-21 abolished the lipogenesis-reducing effect of miR-212 inhibitor in HepG2 cells (+/- FFA), validating FGF-21 as a target gene of miR-212. These data link the benefit of exercise and miR-212 downregulation in preventing NAFLDvia targeting FGF-21.
引用
收藏
页码:204 / 216
页数:13
相关论文
共 50 条
  • [1] miR-149 controls non-alcoholic fatty liver by targeting FGF-21
    Xiao, Junjie
    Lv, Dongchao
    Zhao, Yingying
    Chen, Xiaoyu
    Song, Meiyi
    Liu, Jingqi
    Bei, Yihua
    Wang, Fei
    Yang, Wenzhuo
    Yang, Changqing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (08) : 1603 - 1608
  • [2] Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease
    Kandel, Amrita
    Pant, Poonam
    Todi, Sushila
    Kc, Sudhamshu
    Pandey, Sudip
    SAGE OPEN MEDICINE, 2024, 12
  • [3] Effect of Endurance Exercise on Non-Alcoholic Fatty Liver Disease
    Sullivan, Shelby
    Kirk, Erik P.
    Patterson, Bruce
    Klein, Samuel
    GASTROENTEROLOGY, 2011, 140 (05) : S700 - S700
  • [4] Emerging role of miR-21 in non-alcoholic fatty liver disease
    Benhamouche-Trouillet, Samira
    Postic, Catherine
    GUT, 2016, 65 (11) : 1781 - +
  • [5] miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR
    Sun, Chuanzheng
    Huang, Feizhou
    Liu, Xunyang
    Xiao, Xuefei
    Yang, Mingshi
    Hu, Gui
    Liu, Huaizheng
    Liao, Liangkan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (03) : 847 - 853
  • [6] Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
    Wu, Qiongbo
    Chen, Zihao
    Ding, Yi
    Tang, Yunting
    Cheng, Yawei
    FRONTIERS IN NUTRITION, 2022, 9
  • [7] A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease
    Nobili, V.
    Bedogni, G.
    Alisi, A.
    Pietrobattista, A.
    Alterio, A.
    Tiribelli, C.
    Agostoni, C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (10) : 801 - 805
  • [8] Protective effect of probiotics in patients with non-alcoholic fatty liver disease
    Cai, Gen-shen
    Su, Hui
    Zhang, Jing
    MEDICINE, 2020, 99 (32) : E21464
  • [9] The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease
    Zhang, Dan-Ying
    Zhu, Lin
    Liu, Hai-Ning
    Tseng, Yu-Jen
    Weng, Shu-Qiang
    Liu, Tao-Tao
    Dong, Ling
    Shen, Xi-Zhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2249 - 2270
  • [10] Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice
    Sun, Xue
    Duan, Xingping
    Wang, Changyuan
    Liu, Zhihao
    Sun, Pengyuan
    Huo, Xiaokui
    Ma, Xiaodong
    Sun, Huijun
    Liu, Kexin
    Meng, Qiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 806 : 75 - 82